Latest Articles

Hemp & CBD: Evidence, Evangelism & Extreme Exuberance

By Erik Goldman, Editor

If you are confused about the therapeutic value of hemp oil, cannabidiol (CBD), and other cannabis-related substances, and you’re scratching your head trying to figure out what’s legal and what’s not, that’s good: It means you’re paying attention.  Yes, there is some evidence, but there's also a lot of evangelism. Clinicians face the challenge of separating the scientific realities from the hype. 

Cannabis: State of the Science

By Erik Goldman, Editor

Is there any solid science to support the use of phytocannabinoids in clinical practice? The answer is yes….and no.

It depends on how you define “cannabis” and “cannabinoids;” whether you’re talking about inhaled (ie, smoked or vaped), ingested, or sublingual delivery; and of course, which diseases you’re considering.

Cannabis & Hemp: A Regulatory Update

By Erik Goldman, Editor

The year 2018 was a landmark in the history of hemp and cannabis in the US. It was the year the FDA approved the first natural cannabis-derived prescription drug, and Congress passed a Farm Bill that included provisions legalizing cultivation of, and interstate commerce in, low-THC hemp. But the laws and regulation around hemp and cannabis remain a confusing patchwork, and some states are taking regulatory actions that run counter to the new federal provisions.

Cannabis, Hemp, Marijuana: What's in a Name?

By Erik Goldman, Editor

Amid the current rage for all things cannabis, there is a lot of confusion about the terminology used to describe this plant and compounds extracted from it.

Part of that confusion arises from the Farm Bill of 2018, which changes some federal definitions. These changes have major implications for legal and regulatory policy.  Here’s a guide to common cannabis-related terms and their current definitions.

"I Expect My Patients to Be Outliers": Applying Nutrition to Improve Cancer Outcomes

By Erik Goldman, Editor

“I expect my patients to be outliers, to defy the statistics, to defy the odds,” says Nalini Chilkov, LAc, OMD, a practitioner of oriental medicine and nutrition counseling, who specializes in working with cancer patients.

Over a career spanning more than 30 years, Dr. Chilkov has treated thousands of people with diverse forms of cancer. She’s witnessed first-hand the positive impact that thoughtful, carefully-tailored diets and supplementation protocols can have. She shares a wealth of clinical pearls on how to use nutritional interventions to improve health outcomes for people with cancer.

Why Are Women Still Suffering Through Menopause?

By Decker Weiss, NMD, Contributing Writer

Why do some women seem to move easily through menopause while others suffer greatly? Why do some menopausal women respond well to hormone therapy while others get little relief? The answer may have less to do with sex hormones and more to do with imbalances in the hypothalamus-pituitary-adrenal-thyroid (HPAT) axis.

To Reduce Age-Related Heart Risk, Target the Mitochondria

By August West, Contributing Writer

It’s an unfortunate fact of nature: mitochondrial function tends to decline with age. Along with that comes a host of physiological changes that cumulatively result in the phenomenon we all experience as aging and senescence. Fortunately, a new form of mitochondrially-targeted co-enzyme Q10 can reverse some of these changes. 

Migrants at the Border: US Citizens Head South for Cheap Medical Care

By Erik Goldman

There are a lot of anxious, needy people eager to cross the line that separates the US from Mexico. Go to the border towns of Southern California and Arizona, and you’ll see them--- US citizens heading south to Mexican clinics and farmacias, seeking lower cost surgeries and cheap meds.

Medical and pharmacy “tourism” to Mexico is a large and growing phenomenon, one that has received little attention amid the bitter political rancor over immigration policy and border control.